Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures

Summary

The Chief Medical Officers of England, Scotland, Wales and Northern Ireland have asked NICE to develop guidance on the prevention of transmission of Creutzfeldt-Jacob Disease (CJD).

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on patient safety and reduction of risk of transmission of Creutzfeld-Jakob disease (CJD) via interventional procedures.

Description

CJD is a progressive, fatal neurological disease that belongs to a wider group of neurodegenerative disorders known as transmissable spongiform encephalopathies (TSEs) or prion diseases. Traditionally there are three categories of CJD; sporadic CJD (the most common), inherited CJD and iatrogenic CJD.

A novel form of human prion disease, vCJD was first recognised in the UK in 1996 and is believed to result from consumption of food derived from cattle infected with BSE. Like BSE, vCJD is a fatal neurodegenerative disease that causes sponge-like changes in the brain.

This guidance covers management of all patients undergoing procedures involving instruments and endoscopes that might pose a risk of transmission of CJD. It does not cover dental procedures.

OPCS4.6 Code(s):

This procedure is outside the scope of the OPCS-4 classification.

_{The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS.   The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided.  www.connectingforhealth.co.uk/clinicalcoding}

Details

Contact details:

Links:

	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: guidance (web format)	11 February 2011
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Guidance	22 November 2006
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Guidance (MS Word format)	22 November 2006
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Quick reference guide	22 November 2006
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Understanding NICE guidance	22 November 2006
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Understanding NICE guidance (MS Word format)	22 November 2006
	IPG196 Clefyd Creutzfeldt-Jakob: lleihau'r risg o drosglwyddo drwy offer llawfeddygol: deall canllawiau NICE (fformat MS Word)	15 October 2009
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Costing report	21 November 2006
	Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Audit criteria	15 January 2007
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Final report	21 November 2006
	IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Systematic review	21 November 2006
	2006/054 New NICE guidance to reduce the risk of transmission of Creutzfeldt-Jakob disease (CJD) via surgical procedures	22 November 2006
	CJD: second consultation documents and comments	01 July 2006
	CJD: first consultation documents and comments	28 February 2006
	CJD: project development history	01 October 2004
	Common questions about CJD	01 October 2004
	CJD Advisory Subcommittee	01 October 2004
	Patient safety and reduction of risk of transmission of Creutzfeldt - Jakob disease (CJD) via interventional procedures: Slide Set	09 April 2008